a Archive

It was several years ago when a package from Happy Skin arrived at the office of a publishing house. Unlike countless other cosmetic products sent to editors, this particular package had punch. Bright pastels enveloped blush and powder compacts hinting at the young

Author’s note: This article was presented early to subscribers of the Total Pharma Tracker, and they also got further insight into how best to use these tools in making investment decisions. Biotech holds a special place in my heart, both for the

Doctors have begun a trial of a simple saliva test that aims to spot the top 10% of men who are most at risk of developing prostate cancer. One in eight men develop prostate cancer at some point in their lives. The test draws